This study aimed to compare total IgE levels in patients with hematologic malignancies to those in non-cancer controls.<h4>Methods</h4>In this cross-sectional study in 2023, sixty patients with hematological malignancies and 90 non-cancer patients attending Sari Imam Hospital were evaluated for total IgE levels along with demographic data. This evidence concerns the gene IGHE and hematologic disorder.